Memantine, a long-approved and cost-effective drug used to treat Alzheimer’s disease, could also benefit patients with sickle cell anemia in the future. Initial clinical data from an international ...

Memantine, a long-approved and cost-effective drug used to treat Alzheimer's disease, could also benefit patients with sickle cell anemia in the future. Initial clinical data from an international ...

Chronic pain in young people with sickle cell disease means greater disability, more burden, and lower quality of life, a U.S ...

A Black female doctor when that was rare, she developed a diagnostic test for the disease that is still a standard tool, as ...

Medicaid is doing a novel payment system for the new, promising and expensive sickle cell treatment. It may become a model ...

Some people don’t develop dementia despite showing signs of Alzheimer’s disease in their brain, and we're starting to ...

Strep throat is a common throat infection that often causes a sore throat, fever and trouble swallowing. It tends to come on ...

The COVID-19 pandemic gave us tremendous perspective on how wildly symptoms and outcomes can vary between patients ...

The Central Drugs Standard Control Organisation (CDSCO) has granted multiple CT-18 approvals between January 2020 and ...

Say goodbye to scrolling in the hallways. New Jersey schools are officially going phone-free. On Thursday, Jan. 8, at Ramsey High School, Gov. Phil Murphy signed a new law requiring districts ...

Jan 8 (Reuters) - American Electric ‌Power said on Thursday ‌its unit will buy a substantial portion of its option for solid oxide fuel ‍cells in a deal worth about $2.65 billion as part of ⁠its plans ...